Ahrens Brenton Karl

DirectorIterum Therapeutics plc (ITRM) · full profile →Form 4 · filed Sep 12, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$77K
Net Open-Market Flow
-$77K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 12, 2022Sell(S)15K$2.31$35K82K
Sep 9, 2022Sell(S)15K$2.32$35K97K
Sep 8, 2022Sell(S)3K$2.26$7K112K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-030853) within minutes of acceptance. Every field above traces to the original document. Verify it directly: